4Apdqst J,Bakker K,Van Houtum WH,et al.IntemntionalCon8en8usand practical guidelinesof the management and theprevention of thediabetic foot.International working group onthe Diabet Foot[J].Diabetes Metab Res Rev,2000,16(suppl):84-92.
6Apdq st J,Bakker K,Van Houtum WH,et al.Internntional Con.8en8us and practical guidelines of the management and the prevention of the diabetic foot.International working group on the Diabetes Foot[J].Diabetes Metab Res Rev,2000,16(suppl 1):84-92
7Collins T, Cybulsky MI. NF-kappa B:pivotal mediator or innocent bystander in atherogenesis[J]. J Clin Invest, 2001, 107(3): 255 - 284.
8Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-kappa B activity[J]. Annu Rev Immunol, 2000,18(4) :621 - 663.
